• Question: In light of evidence linking potentially injurious ventilation practice (supraphysiologic tidal volume and low positive end-expiratory pressure) to poorer outcomes after high-risk surgery, we asked whether the clinical management of 1-lung ventilation for thoracic surgery over the study period in several major academic centers reflected changes in this evidence base.
and clinical outcomes. 4 Nonetheless, a significant proportion of patients, particularly previously identified high-risk subgroups (female patients, those with height <165 cm, and obese patients), continue to receive V T and PEEP outside of recommended practice parameters. 5 Although prominent studies, 2, 6, 7 reviews, 1, 8, 9 and expert commentary 8, 9 support combining the use of lower physiologically appropriate V T with PEEP during 1-lung ventilation (1LV), it is not clear that widespread adoption of these evidence-based practices has occurred.
Thoracic surgery patients may be at even greater risk for the injurious processes generated by positive pressure ventilation, and particularly by 1LV, which is itself a risk factor for lung injury. 10 Indeed, the risk of major respiratory complications after thoracic surgery requiring 1LV remains much higher than that of other surgery classes. [11] [12] [13] There are, however, very limited data on the current use of LPV for patients undergoing 1LV. 14, 15 In this multicenter study, we examined variations and trends in the management of 1LV with emphasis on the use of LPV strategies. We hypothesized that (1) a significant percentage of patients continue to be ventilated with potentially injurious larger tidal volumes (V T > 6 mL/kg predicted body weight [PBW] ) and/or minimal PEEP (<5 cm H 2 O) during 1LV, (2) the use of protective 1LV (V T ≤ 6 mL/kg PBW; PEEP ≥5 cm H 2 O) varies as a function of patient characteristicsparticularly high body mass index (BMI), short stature (<160 cm), and female sex, (3) adoption of protective 1LV increased over the study period, and (4) variability existed between institutions in the practice of protective 1LV.
METHODS
Approval for this project was provided by the University of Michigan Institutional Review Board (IRB# HUM24166 and HUM33894, Ann Arbor, MI). The requirement for written consent was waived by the IRB. Data were extracted from anesthesia information system (AIMS) records that were transformed into a standardized format at each participating institution and submitted electronically to the Multicenter Perioperative Outcomes Group (MPOG) centralized database at the University of Michigan. Participation in the MPOG Project requires each participating institution to obtain institutional IRB approval for creation and transmission of a limited dataset to the centralized coordinating center. Research was completed in a manner consistent with the STROBE statement. A completed STROBE checklist is available on request.
Data quality is ensured by a number of sequential quality control processes. First, each MPOG participating institution is independently responsible for mapping AIMS data into MPOG concept identifiers. When complete, a test upload of the data is sent to MPOG. Each participating site performs more than 70 automated MPOG data diagnostics, which were developed to ensure the accuracy of the key data elements being submitted to MPOG. Only after these tasks are completed and necessary corrections made are the data uploaded into the MPOG research database. Third, for several months after the first upload, all sites are required to validate 20 random cases per month; thereafter 5 cases per month are validated. Finally, MPOG programmers regularly perform data diagnostics to ensure the accuracy of transmitted data elements. Further details of the function of MPOG are described elsewhere. 16, 17 All data analysis was performed at the University of Michigan. The study protocol, including primary and secondary outcomes, patient inclusion/exclusion criteria, and a proposed statistical analysis were presented, approved, and registered with the MPOG perioperative clinical research committee before data extraction.
The initial proposal was presented in May 2014, with revisions submitted in July 2014. The following minor modifications (made before data were collected and analyzed) should be noted:
1. The definition of LPV was liberalized to include V T ≤ 6 mL/kg PBW (originally proposed as ≤5 mL/kg) to reflect the upper acceptable limit of this parameter as supported by expert recommendations during the study period. 8, 10 2. The time period used for analysis of "initial" 1LV data was 5-15 minutes postinitiation of 1LV (previously 0-10 minutes) to reflect the fact that ventilator setting changes frequently occur in the initial 5 minutes of 1LV.
Four centers contributed data to this analysis (University of Michigan, University of Virginia, University of Vermont, and University of Tennessee). The contributing centers and the study period (2009-2014) were chosen based on completeness of 1LV data (structured, timed documentation of 1LV) and consistent case volume throughout the study period with the anthropometric data required to complete the analysis. Institutions were selected before assessment of outcome data. Individual cases were included if the patient was >18 years of age, the case included documentation of 1LV initiation and available data permitted the calculation of BMI. Thus, no cases with missing data elements were included in the study. No a priori power calculation was performed as this was a sample of available complete data in the registry. Analyzed ventilator data were as recorded in the AIMS and transmitted to the coordinating center.
We defined 2 time periods for analysis: an "initial" period 5-15 minutes after the charted initiation of 1LV (a delayed start was included to allow for ventilator changes after initiation of 1LV) and an "overall" period which encompassed the entire duration of 1LV based on charted initiation of 1LV and resumption of 2-lung ventilation (2LV). In some institutions, resumption of 2LV was not consistently charted; therefore, we analyzed the dataset for differences between these 2 time periods. By definition, these time periods overlapped. We sought to determine whether studied variables differed between the 2 periods, and if not, planned to maximize available statistical power by using the "initial" period because more subjects would be available. Driving pressure (ΔP; P PLAT − PEEP) was calculated from ventilator data derived from 2 of the 4 institutions (University of Virginia and University of Vermont) which reported P PLAT data. 
Statistical Analysis
Statistical analysis was performed using SPSS version 21 (SPSS Inc, Chicago, IL) and STATA MP version 14 (STATA Corp, College Station, TX). All data were analyzed for normality. Normally distributed data are presented as mean ± standard deviation. Nonnormally distributed data are presented as medians (25th-75th percentile). The initial V T for each individual patient (case) was not normally distributed and therefore the median value was calculated for each patient (case). The distribution of initial V T for the study population was normally distributed and therefore the sample mean of the individual patient's median initial V T is reported along with standard deviations. To assess the presence of statistically and clinically relevant differences between initial and overall tidal volumes (mL/kg PBW), a paired samples t test was performed. To assess whether the proportion of cases with PEEP ≥5 cm H 2 O versus PEEP <5 cm H 2 O and the proportion of cases with LPV versus those without LPV differed for initial V T and overall V T time periods, a Pearson χ 2 test was used. We assessed the association between mean driving pressure and the factors obesity (yes versus no), gender, and stature (short versus nonshort) using the Student t test. To assess statistically significant differences in V T across the institutions for nonnormally distributed data, independent samples Kruskal-Wallis test was used with Bonferroni correction. A P value of .0125 was considered statistically significant for these tests. We used a linear regression model to determine if there were significant interactions between the institution and each of the 3 subgroups; obesity (yes versus no), gender, and stature (short versus nonshort). The dependent variable was the V T . Analysis of variance was used to assess statistically significant differences between institutions for V T and the use of protective 1LV.
A mixed effects logistic regression model was developed to assess independent predictors of LPV (dependent variable) controlling for patient factors (age, gender, BMI, height, American Society of Anesthesiologists [ASA] classification status) and individual year (where 2009 was the reference year) as fixed effects and the individual MPOG institution as a random effect. A P value of <.05 was considered statistically significant for fixed effects covariates. The intraclass correlation (ICC) is reported for the variation in LPV due to the variability between the institutions.
All cases from the participating institutions meeting the inclusion criteria during the study period (January 2, 2009, to December 30, 2014) were included in the analysis. There were 328 cases during the first 6-month study period and 445 subjects during the last 6-month period. There is a 91.2% power to detect a difference of 8% in LPV between the 2 periods assuming a percentage of 9.1 (30 of 328) during the first 6-month study period using a 2-sided Z test with unpooled variance and a significance level of .05.
RESULTS
Data from 5609 patients across the 4 institutions were included in the analysis. The 2 data periods (overall versus initial) were compared. The median period of 1LV was 117 minutes (interquartile range, 59-186). Mean of the median initial V T was not different from the mean of the median overall V T (6.49 ± 1.82 mL/kg PBW vs 6.47 ± 1.57 mL/kg PBW; P = .856) (Table) . Median PEEP in the initial and overall periods was 5 cm H 2 O (data not shown), suggesting that only minor modifications of PEEP occurred beyond the initial observation period. Use of PEEP ≥5 cm H 2 O in the initial intraoperative period was 50.2% vs 46% in the overall period (P < .001); no difference was found in the rate of LPV between intraoperative periods: 23% (initial) vs 20% (overall) (P = .174). 6.00 ± 1.56
Table. Median Initial V T (mL/kg PBW) Per Institution by Subgroup Analysis
Patient counts for each institution and the entire cohort and median initial V T (mL/kg PBW or ABW) for the cohort and median initial V T (mL/kg PBW) for highrisk subgroups-BMI >30 kg/m 2 , height <165 cm, and female sex. Abbreviations: ABW, actual body weight; BMI, body mass index; PBW, predicted body weight; V T , tidal volume. a Statistically significant interinstitution variability in overall initial V T (mL/kg PBW); P < .001. The proportion of cases with PEEP ≥5 cm H 2 O increased from 53% during the first 6-month period in 2009 to 91% in the final period in 2014 (P < .001; Figure 1 ). Median V T (mL/kg PBW) declined during the study period from 6.88 ± 1.98 in 2009 to 5.72 ± 1.45 in 2014 (P < .001; Figure 2 ).
The use of LPV rose during the study period from 9.1% in 2009 to 55% in 2014 (Figure 3 ). While PEEP ≥5 cm H 2 O was used in the majority of cases from 2011 onward, median V T remained above 6 mL/kg (PBW) until early 2014 (mean of the median V T ± standard deviation for 2013 and 2014: 6.22 ± 1.66 and 5.67 ± 1.45, respectively).
Each of the 3 subgroups previously identified as being at higher risk of receiving large V T 5 during 2LV also received larger V T during 1LV relative to that of the overall cohort (Table, Figure 2 ). There were no statistically significant interactions between institution and each of the 3 subgroups with regard to the V T . Of 5609 patients included in the study, 32% were obese (BMI >30 kg/m 2 ), 33% were of short stature (height <165 cm), and 46% were female. Administered V T was larger for each of the high-risk subgroups as compared with the cohort as a whole (6.49 mL/kg PBW) (Table) . Administered V T was larger for female patients (compared to male patients; 7.05 ± 1.92 mL/kg PBW vs 6.00 ± 1.56 mL/kg PBW; P < .001), those with short stature (<165 cm compared to >165 cm; 7.33 ± 2.01 mL/kg PBW vs 6.09 ± 1.57 mL/kg PBW; P < .001) or obesity (compared to nonobese patients; 6.86 ± 1.97 mL/kg PBW vs 6.31 ± 1.70 mL/kg PBW; P < .001). The use of PEEP ≥5 cm H 2 O was more frequent in obese patients (68%) than in those who were nonobese (59%; P < .001), with short stature (59%) or female sex (61%) (P < .001). A lower proportion of patients in the high-risk subgroups received LPV when compared with the remainder of the cohort: female versus male (18% vs 32%; P < .001), short stature (<165 vs >165 cm [14% vs 30%; P < .001]), and obese versus nonobese (23% vs 36%; P = .021).
Results of the mixed effects logistic regression model demonstrated the ICC for institution as a random effect was 0.46 (95% confidence interval, 0.09-0.88), which means that an estimated 46% of the variation in LPV is due to variability between hospitals and 54% of the variation is due to variability within hospitals.
Interinstitutional differences were seen in median tidal volumes, PEEP, and the use of LPV. The absolute difference in the median initial V T for the duration of the study between institutions was 0.6 mL/kg (range, 6.28-6.88 mL/kg; P < .001; Table) . The use of PEEP ≥5 cm H 2 O varied significantly between institutions (32.3%-76.8%: P value < .001; data not shown). The use of protective 1LV also varied markedly (range, 0%-31%) between institutions throughout the study period (P < .001; data not shown).
Data on driving pressure were available from 2 institutions within the study with a total of 1890 cases analyzed. Driving pressure fell during the study period from 19.4 ± 6.4 cm H 2 O during period 1 to 16.4 ± 5.7 cm H 2 O in period 11 and 17.3 ± 5.9 cm H 2 O in period 12 (P = .003, F statistic 2.625; Figure 4) (Figure 4) .
DISCUSSION
In this multiinstitutional study of 1LV practice, we found that median V T declined and the use of PEEP ≥5 cm H 2 O increased during the study period. This decline in median V T and adoption of PEEP during 1LV accounted for a dramatic increase in the proportion of patients receiving LPV.
It is important to note that the current study does not attempt to demonstrate the clinical efficacy of LPV, but rather to describe clinical practice patterns of 1LV. The definition of LPV used herein reflects limits derived from clinical trial data 6 and recommendations by experts 8 and represents a relatively liberal approach to the definition. Not surprisingly, small variations in the upper limit of acceptable 1LV V T exist. Several clinical studies appear to support a lower V T limit (5 mL/kg) 2, 7, 19 than the definition used in this study (V T ≤6 mL/kg PBW; PEEP ≥5 cm H 2 O). The use of a lower V T limit would certainly have resulted in an even lower reported proportion of patients receiving LPV.
These reported practice changes also explain the decrease in ΔP during 1LV observed in our study population. However, despite increasing adherence to recommended ventilation practices, large variations in clinical practice between institutions were observed with only approximately half of the cohort receiving LPV at the end of the study period. Moreover, high-risk subgroups, patients with obesity, short stature, and females received larger median V T and a lower frequency of LPV relative to the overall cohort and obese patients were also exposed to higher ΔP.
1LV and Lung Injury
1LV contributes to the development of lung injury and complications after thoracic surgery. 1, 10 Mechanisms by which such injury may occur include lung strain, atelectasis, cyclic recruitment/derecruitment phenomena, oxidative stress, and capillary shear stress. Although the ideal ventilation management regimen for 1LV has not yet been identified, support for putative protective 1LV comes from trials in patients with preestablished lung injury, 18 surgical patients receiving 2LV, 3, 4 and small studies of patients undergoing thoracic surgery with 1LV. 2, 6, 7 Most prospective studies examining protective 1LV have demonstrated improvements in clinical outcomes or surrogate markers of lung injury. 2, 6, 7, 19 A retrospective clinical study examining outcomes before and after institution of an LPV protocol also support a LPV strategy utilizing reduced V T , increased PEEP, limited airway pressures, and recruitment maneuvers. 20 It is important to note that low V T regimens per se may not be inherently protective. That is, in the absence of other strategies needed to prevent atelectasis-adequate PEEP and recruitment maneuvers-low V T may predispose to atelectasis. Possibly because of greater compressive forces exerted on the dependent ventilated lung during 1LV and the use of higher inspiratory oxygen fractions, atelectasis and atelectrauma resulting from cyclic recruitment/derecruitment phenomena may be more common and problematic during 1LV. Atelectasis of the ventilated lung is a prominent feature of 1LV, has been demonstrated in an elegant animal model, 21 and is supported by studies demonstrating improved gas exchange 22, 23 and pulmonary mechanics 21 after recruitment maneuvers. Once adequately recruited, the dependent ventilated lung during 1LV may require a critical level of PEEP to prevent cyclic recruitment and/or collapse. A recent study of surgical patients receiving either high or low V T regimens with an equivalent level of PEEP revealed no difference in postoperative pulmonary function. 24 Low V T with minimal PEEP (<5 cm H 2 O) has been identified as (1) a risk factor for mortality in a large surgical cohort receiving 2LV, 25 (2) is associated with the risk of postoperative respiratory complications in thoracic surgical patients receiving 1LV, 26 and (3) leads to pulmonary inflammation and impaired oxygenation in patients undergoing hepatectomy. 27 Taken together, the bulk of available evidence supports the view that protective 1LV requires physiologically appropriate (low) V T and a level of PEEP sufficient to prevent both an injurious level of tidal strain and tidal recruitment/derecruitment phenomena.
Practice Patterns of 1LV Management
Recommendations reflecting theoretical, experimental, and clinical evidence for protective 1LV have been published 1, 8 and may be contributing to a gradual change in clinical practice. In the current study, we saw statistically and clinically significant decreases in median V T over the 6-year study period from 2009 to 2014, and significant increases in the proportion of patients receiving PEEP ≥5 cm H 2 O and ventilated in a manner that met our criteria for LPV.
Although very little is known about practice patterns of 1LV, it appears that changes in clinical practice have been slow. Surveys of self-reported 1LV practice in the United Kingdom and Italy suggest that approximately half 14 or fewer 15 respondents target V T of 6 mL/kg or less, but these results are inherently subjective and subject to reporting bias. In a single-center study of 1LV practice patterns, we have previously found that practitioners continued to use high V T and low PEEP relative to recommendations. 26 When delivered V T was normalized to PBW, 43% of patients in the studied cohort were ventilated with V T >6 mL/kg and only 47% received PEEP greater than 5 cm H 2 O. In the present multicenter cohort study, the overall median V T normalized to PBW was 6.49 mL/kg, but a significant decrease was seen over the 6-year study period.
Numerous factors may contribute to the slow implementation of LPV in the management of surgical patients. First, there is a perception that the control groups used in recent prominent prospective trials 3,4,28 did not reflect modern practice with regard to PEEP (zero or very low PEEP), potentially confounding interpretation. Second, the use of low V T per se (ie, without adequate PEEP) does not appear to be intrinsically protective, [24] [25] [26] [27] potentially confounding a simple interpretation of the available data. Additionally, reader skepticism, practice inertia, and the need for accrual of a critical mass of clinically relevant information and expert opinion may all contribute to the slow adoption of LPV strategies.
Previous studies have demonstrated that, in surgical patients undergoing 2LV, female patients, obese patients, or short stature patients received larger median V T on the basis of PBW and consequently, that a smaller proportion of these subgroups received LPV. 5, 29 A similar phenomenon was observed in the present study of thoracic surgery patients receiving 1LV. Previously defined high-risk subgroups received significantly larger V T on the basis of PBW; 6.86 for BMI >30 kg/m 2 , 7.05 for female patients, and 7.33 for patients of short stature (height <165 cm). The delivery of greater V T in these patient subgroups may be unintentional and may occur for a number of reasons. First, many anesthesia machines do not calculate PBW. Second, the anesthesiologist may fail to correct for the discrepancy between actual and PBW because of a lack of awareness regarding its significance. Third, modern anesthesia machines are generally programmed with preset default values for ventilator parameters such as V T and PEEP. In many cases, these default values may not reflect modern clinical practice standards but may continue to influence clinical practice. Clinically significant changes in ventilatory practice can be accomplished by simply modifying these default values (unpublished observations) or modernizing anesthesia equipment. 30 Another important finding of this study is the variability in 1LV practice between institutions. Despite similarities among the 4 institutions from which the data were derived (all are large tertiary, academic centers), median V T during the study period varied significantly. Much more variability was seen in the proportion of cases for which LPV was utilized. LPV utilization varied from approximately 30% in institution 1 to 0% in institution 2, reflecting differences in application of both V T and PEEP. Even after adjustment for patient fixed effects, including patient complexity using the ASA classification, the large ICC observed in the mixed effects model demonstrates the significant impact of institution on patient management. A significant variation in the use of high V T 2LV between institutions has been reported in a prior MPOG report and is likely related to differences in equipment, culture, academic interests, and familiarity with the pertinent literature.
The reduction in V T and increased utilization of moderate PEEP levels over the study period was also associated with a decrease in levels of ΔP seen in the 2 institutions from which these data were available. This finding is likely to be of clinical significance, given the relatively recent identification of ΔP as an important predictor of survival in acute respiratory distress syndrome, 31 the association between ΔP and pulmonary complications in surgical patients, 32, 33 and the recently reported relationship between ΔP during 1LV and morbidity after thoracic surgery. 26 While it is not clear what level of ΔP is protective or "safe" during 1LV, data presented herein provide evidence that improved adherence to LPV recommendations is associated with reductions in ΔP. Further studies controlling for ΔP will be required to identify levels needed to limit iatrogenic lung injury during both 2LV and 1LV.
Limitations
Several study limitations should be noted. First, this study reports on practice patterns and is not able to provide information on the putative relationship between observed ventilation trends and resultant changes in clinical outcomes that may have resulted from these changes. Such an endeavor would require an interface between the intraoperative electronic medical record and a database containing information on postoperative outcomes. Efforts are being made to establish such an interface and pursue this line of investigation. However, it is worthwhile to restate the well-established role of, and recommendations for, LPV in improving clinical outcomes in both general surgical and thoracic surgical patients undergoing 1LV. Second, this is a multicenter study utilizing data from MPOG member institutions. These contributing centers use different electronic medical record systems and data from these medical records are subsequently combined into a single database. Although the methodologies for mapping objective concepts are rigorously validated, there is a potential for error. Third, the 4 contributing centers are relatively homogeneous in the sense that they are large, tertiary academic medical centers. As such, practice within these centers over the study period may not be representative of current practice at other institutions. Although the inclusion of the chosen centers was guided exclusively by the aforementioned inclusion criteria, a selection bias is possible. It should be noted that none of the centers contributing data for the current study had protocols guiding the management of 1LV during the study period. The large degree of variation in practice with regard to 1LV among these institutions raises the possibility that practice at other types of centers may be even more disparate in nature. Although, ASA physical status classification data were used to adjust for patient complexity, we were unable to adjust for surgical complexity in our mixed-effect logistic regression model. Fourth, while the analyzed dataset contained date of surgery data, no protected health information was available. Therefore, it is possible that some subjects may have had multiple operations. Including patients with multiple procedures without adjusting for the likely within-subject correlation
